InvestorsHub Logo
Boards
News
Market Data
Markets
Discover
Discover
AI Subscribe Login/Register account icon
S&P 500
5,702.55
(
-0.19%
)
US TECH 100
19,295.98
(
-0.20%
)
Dow Jones
42,063.36
(
0.09%
)
Brent Oil
74.01
(
-0.42%
)
Bitcoin
62,769.70
(
-0.29%
)
Post# of 672
Next 10
Reply Private New
Public Reply Private Reply New Post
Keep Last Read
Keep Next 10 Report Keyboard Shortcuts
Next 10 Prev Next

Aloha922

Send PM Follow Ignore
Followers 0
Posts 115
Boards Moderated 0
Alias Born 09/16/2016

Aloha922

Re: realfast95 post# 317

Thursday, 03/30/2017 7:18:53 AM

Thursday, March 30, 2017 7:18:53 AM

Post# of 672
Great to see they are moving right along. I also like that management does not want to back down from the FDA.


"Now with ARYMO ER stocked at key wholesale distribution locations and having begun discussions with payers, our salesforce is well positioned to begin educating healthcare providers about the risks and benefits of ARYMO ER," said Bob Radie, president and chief executive officer of Egalet. "ARYMO ER strengthens our portfolio of pain products which includes SPRIX® Nasal Spray and OXAYDO®."
Public Reply Private Reply New Post
Keep Last Read
Keep Last Read Next 10 Report Keyboard Shortcuts
Next 10 Prev Next
Join InvestorsHub

Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.

Sign Up